Diabetes News Archive

New research on Type 2 diabetes by Trinity College Dublin researchers could benefit young adults (aged 18-25 years) with the condition.

Metformin XR (extended release formulation) -- a medication used to treat type 2 diabetes -- appears to cause a small but significant decrease in body mass index (BMI) in non-diabetic obese adolescents when combined with a lifestyle intervention program, according to a report in the February issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

MONDAY, Feb. 1 (HealthDay News) -- A medication used to treat type 2 diabetes appears to help overweight teenagers lose weight when combined with a program designed to help them change their lifestyle habits, researchers report.

DUBAI - A diabetes corner which provides A to Z of all the information, drugs, medical devices and special types of food items is something that any diabetic patient would want to see in their neighbourhood pharmacy.

New research on Type 2 diabetes by Trinity College Dublin researchers could benefit young adults (aged 18-25 years) with the condition. The research led by Professor John Nolan of Trinity College Dublin and St James's Hospital, Dublin, has just been published online in the leading international journal, Diabetes Care.

A new web site that caters to the entire diabetes community is available at www.DiabetesCare.net (http://www.DiabetesCare.net). As well as providing self-care information and solutions, the site focuses on latest trends, studies and breaking news about the disease on a daily basis.

New PSA Released Featuring Congressman James E. Clyburn, Asks Those Living With Diabetes to Pledge to Get Eye Exam in February

SAN FRANCISCO, CA--(Marketwire - 02/01/10) - In recognition of Black History Month, House Majority Whip James E. Clyburn is urging African Americans with diabetes to get an annual diabetic eye exam during February. The message, released in a new public service announcement produced in conjunction with the American Academy of Ophthalmology's (AAO) EyeSmart campaign and the Stop Diabetes(SM ...

The study findings demonstrate new mechanisms in muscle cells that may explain severe insulin resistance and a reduced response to aerobic exercise in young obese patients with type 2 diabetes. These important findings will contribute in the long-term to the development of more specific treatments for young people with type 2 diabetes.

( Trinity College Dublin ) The study findings demonstrate new mechanisms in muscle cells that may explain severe insulin resistance and a reduced response to aerobic exercise in young obese patients with type 2 diabetes. These important findings will contribute in the long-term to the development of more specific treatments for young people with type 2 diabetes.

Website features interactive nutrition and exercise tools, the latest breaking news and studies, plus blogs, forums, recipes and a 'Knowledge Center' that can all be tailored to an individual visitors needs, while also catering to diabetes caregivers and providers.

The federal Food and Drug Administration has OKd a new, once-a-day diabetes drug. In studies, the injectable drug, called Victoza, helped people with Type 2 diabetes control blood sugar and lose weight when they also ate a healthy diet and exercised. The drug is in the same class as Byetta, taken twice a day. Victoza can be prescribed alone or with other diabetes medicines, though it hasn't been ...

Three daily servings of whole grains are recommended for prevention of type 2 diabetes, coronary heart disease, and excess weight gain. Yet few adolescents or young adults follow these guidelines, according to national survey data. In a study published in the February 2010 issue of the Journal of the American Dietetic Association, researchers from the School of Public Health, University of ...

No cure has been discovered for Type 1 diabetes, a disease in which the body's immune system destroys the part of the pancreas that regulates blood sugar. But researchers say they are making strides to develop an artificial pancreas that will eliminate some of the daily challenges that Type 1 diabetics face and protect them against health issues such as blindness or coma.

Perhaps more than ever, advances in diabetes treatment and education are helping people with the disease to live longer, healthier and happier lives. Many people, however, still experience serious complications that often can be delayed or prevented altogether with better practices.

Work for a cure for type 1 diabetes Richard Insel, M.D., Chief Scientific Officer, Juvenile Diabetes Research Foundation - New York I read with interest USA TODAY's piece "Transplant brings troubles, gifts," in which writer Scott Bowles looks back on...

Professor Vincent Marks, a leading authority on the forensic aspects of hypoglycemia and its role in criminal behavior, discusses how hypoglycemia-related neuroglycopenia can cause behavioral changes, which can bring people with diabetes into conflict with the law. "